Clinical trial
Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil…
NCT00312169 · Orlando Immunology Center, Other · Completed
Key facts
| NCT number | NCT00312169 |
|---|---|
| Title | Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA) |
| Official title | Evolution of L74V or K65R Mutations in VIremic Subjects on TDF or ABC (EVITA) |
| Lead sponsor | Orlando Immunology Center, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 20 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Apr 7, 2006 |
| Last update posted | May 22, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: